CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Baseline messageWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (13)


Name (Synonyms) Correlation
drug642 Control message Wiki 1.00
drug1651 Not bravery message Wiki 1.00
drug618 Community interest message Wiki 1.00
drug170 Anger message Wiki 1.00
drug149 Alteplase 100 MG [Activase] Wiki 1.00
drug838 Embarrassment message Wiki 1.00
drug823 Economic freedom message Wiki 1.00
drug1019 Guilt message Wiki 1.00
drug150 Alteplase 50 MG [Activase] Wiki 1.00
drug1798 Personal freedom message Wiki 1.00
drug822 Economic benefit message Wiki 1.00
drug2217 Self-interest message Wiki 1.00
drug2565 Trust in science message Wiki 1.00

Correlated MeSH Terms (6)


Name (Synonyms) Correlation
D013577 Syndrome NIH 0.11
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Persuasive Messages for COVID-19 Vaccine Uptake: a Randomized Controlled Trial, Part 1

This study tests different messages about vaccinating against COVID-19 once the vaccine becomes available. Participants are randomized to 1 of 12 arms, with one control arm and one baseline arm. We will compare the reported willingness to get a COVID-19 vaccine at 3 and 6 months of it becoming available between the 10 intervention arms to the 2 control arms. Study participants are recruited online by Lucid, which matches census based sampling in online recruitment.

NCT04460703 Vaccination COVID-19 Other: Control message Other: Baseline message Other: Personal freedom message Other: Economic freedom message Other: Self-interest message Other: Community interest message Other: Economic benefit message Other: Guilt message Other: Embarrassment message Other: Anger message Other: Trust in science message Other: Not bravery message

Primary Outcomes

Description: This is a self reported measure, immediately after the intervention message, of the likelihood of getting a COVID-19 vaccination within 3 months and then 6 months of it becoming available. During analysis, responses among those assigned to different intervention messages will be compared to those in the control group.

Measure: Intention to get COVID-19 vaccine

Time: Immediately after intervention, in the same survey in which the intervention message is provided

Secondary Outcomes

Description: This is a validated scale. This scale will be used to assess the impact of the messages on vaccine confidence. (Outcome assessed only for the half of the sample that answers these items post-treatment)

Measure: Vaccine confidence scale

Time: Immediately after intervention, in the same survey in which the intervention message is provided

Description: This is a measure of a willingness to persuade others to take the COVID-19 vaccine.

Measure: Persuade others item

Time: Immediately after intervention, in the same survey in which the intervention message is provided

Description: This is a measure of a comfort with an unvaccinated individual visiting an elderly friend after a vaccine becomes available

Measure: Fear of those who have not been vaccinated

Time: Immediately after intervention, in the same survey in which the intervention message is provided

Description: This is a scale composed of 4 items measuring the trustworthiness, selfishness, likeableness, and competence of those who choose not to get vaccinated after a vaccine becomes available

Measure: Social judgment of those who do not vaccinate

Time: Immediately after intervention, in the same survey in which the intervention message is provided


No related HPO nodes (Using clinical trials)